Galmed Pharmaceuticals (GLMD) EPS (Weighted Average and Diluted) (QoQ) (2014 - 2020)
Galmed Pharmaceuticals (GLMD) EPS (Weighted Average and Diluted) (QoQ) (2014 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
-17.34% |
| Dec 31, 2019 |
83.64% |
| Mar 31, 2019 |
6.50% |
| Dec 31, 2018 |
429.21% |
| Sep 30, 2018 |
-77.41% |
| Jun 30, 2018 |
-5.34% |
| Mar 31, 2018 |
-38.13% |
| Dec 31, 2017 |
28.81% |
| Sep 30, 2017 |
2.46% |
| Jun 30, 2017 |
-20.09% |
| Mar 31, 2017 |
-34.78% |
| Dec 31, 2016 |
30.61% |
| Sep 30, 2016 |
-16.31% |
| Jun 30, 2016 |
2.06% |
| Mar 31, 2016 |
31.73% |
| Dec 30, 2015 |
23.27% |
| Sep 30, 2015 |
10.45% |
| Jun 30, 2015 |
-7.50% |
| Mar 31, 2015 |
28.67% |
| Dec 30, 2014 |
-37.68% |
